Contract Research Organisations (CROs)

#Contract Research Organisations (CROs) #Digitalisation #Proscia #Research #Therapeutics

Key findings from life sciences digital pathology adoption survey 

Nearly three-fourths of life sciences organisations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia. Over half of these organisations (53%) still center their operations around legacy software systems primarily for basic image viewing despite growing adoption of… Read More

#Editor's Choice #News

#Biopharmaceuticals #Collaboration #Contract Research Organisations (CROs) #Cryo-EM #Drug research #Immunology #Oncology

What’s next for this integrated drug discovery collaboration? 

Galapagos and NovAliX have entered a strategic collaboration in which Galapagos’ research and discovery capabilities and exclusively related employees based in Romainville, France, will be transferred to NovAliX, a drug discovery-focused Contract Research Organisation. The agreement follows Galapagos’ renewed focus on its key therapeutic areas of oncology and… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Contract Research Organisations (CROs) #Machine learning #Rare disease #Rare Disease Day

How AI can be utilised to improve rare disease drug development

By Lucy Radley, Head of EU Regulatory Development, ProPharma. A rare disease is defined as a condition which affects less than one in 2000 people. Although individually they are very rare, collectively they are common with one in 17 people (around 3.5 million) in the UK being affected by a… Read More

#Exclusive Content #Opinion

#Clinical trial design #Clinical trials #Contract Research Organisations (CROs) #Decentralised clinical trials

Choosing the right site solution for clinical trials

Listen to this article on the DDW podcast: Independent Medical Writer Leonie Onslow explores the challenges of traditional clinical trial models and how to improve recruitment and retention. Covid-19 and the subsequent strain on health systems and research capabilities has created the opportunity to change the traditional clinical trial model of… Read More

#Exclusive Content

Women working in laboratory
#Contract Research Organisations (CROs) #Cpl Sciences #Life sciences #Syneos Health

Record-breaking year for scientific clinical jobs in Europe

According to a report by Cpl Life Sciences and Vacancysoft, 2022 has remained consistently steady for the life sciences industry in Europe in terms of recruitment, though still below 2021 levels.  The yearly forecast shows that vacancies could reach around 13,684 by the end of 2022, a… Read More

#News

Cell and gene therapy
#Cell and gene therapy #Contract Research Organisations (CROs)

CRO opens dedicated cell and gene therapy centre

Clinical research organisation (CRO) Emmes has unveiled a dedicated centre to expand its cell and gene therapy research.  The new centre will offer research services in clinical trial operations, study leadership, statistical services, data management, and pharmacovigilance.  Adam Mendizabal has been named the scientific leader… Read More

#News

#Biomarkers #Clinical trials #Contract Research Organisations (CROs)

Digital biomarkers in pharma: Q&A with Medidata’s Mark Matson 

DDW sits down with Mark Matson, Senior Solution Specialist for Sensor Cloud at Medidata, a Dassault Systèmes company, about the use of digital biomarkers in life sciences and how they can help advance our understanding of disease.  How do we define digital biomarkers?  Digital biomarkers are data, or metrics, collected using digital… Read More

#Exclusive Content